AI/ML-enabled medical device firms paid $39.7 million for radiology devices from 2017–2023, raising transparency concerns.
Key Details
- 1AI/ML-enabled medical device developers paid $39.7M for radiology devices over seven years.
- 2Total industry payments to healthcare entities reached $179M in the same period; only cardiovascular devices saw more ($59.4M).
- 3Researchers identified 846 FDA-listed AI/ML-enabled medical devices, but only 79 (9.3%) disclosed payment data.
- 4Annual payments rose from $17.3M in 2017 to $24.6M in 2023, with general payments doubling from $6.6M to $13.3M.
- 5The number of physician and hospital payment recipients more than doubled, but most manufacturers reported no payments.
- 6Study suggests underreporting may occur due to differing device clearance, reimbursement, and classification pathways.
Why It Matters
Financial incentives from AI device manufacturers may influence adoption and promotion decisions in radiology, underlining the importance of transparency. Calls for modernized disclosure requirements could affect radiology-AI industry practices and regulatory oversight.
Source
AuntMinnie
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•AuntMinnie
Deep Learning Models Rival Radiologists for Pancreatic Cancer Detection on CT
Deep-learning models achieved comparable or superior accuracy to experienced radiologists in detecting pancreatic cancer on CT scans, especially for small tumors.
•Radiology Business
Radiology AI Devices at Elevated Risk for FDA Recalls, Study Finds
Radiology AI devices are more likely to face FDA recalls, largely due to deviations from intended use and incomplete clinical data.